Patents by Inventor Hans C. Reiser

Hans C. Reiser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100160370
    Abstract: The present invention relates to methods, uses, and compositions comprising the caspase inhibitor (R)-N-((2S,3S)-2-(fluoromethyl)-2-hydroxy-5-oxo-tetrahydrofuran-3-yl)-5-isopropyl-3-(isoquinolin-1-yl)-4,5-dihydroisoxazole-5-carboxamide, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 19, 2009
    Publication date: June 24, 2010
    Applicant: Gilead Sciences, Inc.
    Inventors: Howard S. Jaffe, Hans C. Reiser, Clifford Dean Wright
  • METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100008867
    Abstract: The present invention relates to methods, uses, and compositions comprising the caspase inhibitor (R)-N-((2S,3S)-2-(fluoromethyl)-2-hydroxy-5-oxo-tetrahydrofuran-3-yl)-5-isopropyl-3-(isoquinolin-1-yl)-4,5-dihydroisoxazole-5-carboxamide, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 19, 2009
    Publication date: January 14, 2010
    Applicant: Gilead Sciences, Inc.
    Inventors: Howard S. Jaffe, Hans C. Reiser, Franck Rousseau, Geoffrey Yuen
  • Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
    Patent number: 6846643
    Abstract: The present invention relates generally to a method for identifying molecules that bind the R7.1 epitope of LFA-1 or bind LFA-1 such that the R7.1 epitope is modified. The present invention further relates to a method for determining occupancy of the LFA-1 receptor by molecules that bind to the R7.1 epitope or bind LFA-1 such that the R7.1 epitope is modified after administration to a subject. The present invention further relates to molecules useful in the methods of the invention.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: January 25, 2005
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Joseph R. Woska, Jr., Robert Rothlein, Rene M. Lemieux, Hans C. Reiser, Gary O. Caviness, Takashi Kishimoto, Kathleen Last-Barney
  • Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
    Publication number: 20030175814
    Abstract: The present invention relates generally to a method for identifying molecules that bind the R7.1 epitope of LFA-1 or bind LFA-1 such that the R7.1 epitope is modified. The present invention further relates to a method for determining occupancy of the LFA-1 receptor by molecules that bind to the R7.1 epitope or bind LFA-1 such that the R7.1 epitope is modified after administration to a subject. The present invention further relates to molecules useful in the methods of the invention.
    Type: Application
    Filed: March 4, 2003
    Publication date: September 18, 2003
    Inventors: Joseph R. Woska, Ronald L. Magolda, Rene M. Lemieux, Robert Rothlein, Hans C. Reiser, Gary O. Caviness, Takashi Kishimoto
  • Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
    Publication number: 20020068305
    Abstract: The present invention relates generally to a method for identifying molecules that bind the R7.1 epitope of LFA-1 or bind LFA-1 such that the R7.1 epitope is modified. The present invention further relates to a method for determining occupancy of the LFA-1 receptor by molecules that bind to the R7.1 epitope or bind LFA-1 such that the R7.1 epitope is modified after administration to a subject. The present invention further relates to molecules useful in the methods of the invention.
    Type: Application
    Filed: August 6, 2001
    Publication date: June 6, 2002
    Inventors: Joseph R. Woska, Ronald L. Magolda, Rene M. Lemieux, Robert Rothlein, Hans C. Reiser, Gary O. Caviness, Takashi Kishimoto